✦ LIBER ✦

Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma

✍ Scribed by Jennifer A. Quinn; Sara Xiaoyin Jiang; David A. Reardon; Annick Desjardins; James J. Vredenburgh; Sridharan Gururangan; John H. Sampson; Roger E. McLendon; James E. Herndon II; Henry S. Friedman

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 129 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of irinotecan plus temozol

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

✍ David A. Reardon; Jennifer A. Quinn; Jeremy N. Rich; Annick Desjardins; James Vr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Phase II trial of irinotecan plus celeco

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

✍ David A. Reardon; Jennifer A. Quinn; James Vredenburgh; Jeremy N. Rich; Sridhara 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract ## BACKGROUND In the current study, the authors report a Phase II trial of irinotecan (CPT‐11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COX‐2 inhibitor, among MG patients with recurrent disease. ## METHODS Patients with MG at any

Phase 2 trial of combination thalidomide

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

✍ Joseph I. Clark; James Moon; Laura F. Hutchins; Jeffrey A. Sosman; W. Martin Kas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Phase II trial of irinotecan plus cispla

Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck

✍ Jill Gilbert; Anthony Cmelak; Yu Shyr; James Netterville; Brian B. Burkey; Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views